Ligand validation:5HXP

IPR: ISOPENTYL PYROPHOSPHATE

IPR is a Ligand Of Interest in 5HXP designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5HXP_IPR_C_405	77%	41%	0.116	0.956	0.88	1.42	-	4	0	0	100%	1
5HXP_IPR_C_404	62%	38%	0.149	0.942	0.91	1.52	-	2	0	0	100%	1
5HXP_IPR_A_401	22%	33%	0.246	0.865	0.97	1.67	-	2	0	0	100%	1
5HXT_IPR_A_403	25%	27%	0.215	0.849	1.03	1.87	1	4	0	0	100%	0.8857
6VJC_IPR_A_404	99%	50%	0.057	0.986	0.66	1.24	-	2	0	0	100%	1
2ZRW_IPR_A_701	94%	41%	0.085	0.986	1.13	1.16	1	1	1	0	100%	1
6WW1_IPR_B_404	85%	60%	0.109	0.976	0.54	0.97	-	1	2	0	100%	1
6W7I_IPR_A_405	85%	42%	0.105	0.971	1.15	1.1	1	-	0	0	100%	1
4H5E_IPR_F_402	73%	20%	0.152	0.981	1.3	2.04	2	6	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.